| Scope and impact of financial conflicts of interest in biomedical research: a systematic review JE Bekelman, Y Li, CP Gross Jama 289 (4), 454-465, 2003 | 2399 | 2003 |
| Comparison of site of death, health care utilization, and hospital expenditures for patients dying with cancer in 7 developed countries JE Bekelman, SD Halpern, CR Blankart, JP Bynum, J Cohen, R Fowler, ... Jama 315 (3), 272-283, 2016 | 479 | 2016 |
| NCCN guidelines insights: Prostate cancer, version 1.2021: Featured updates to the NCCN guidelines E Schaeffer, S Srinivas, ES Antonarakis, AJ Armstrong, JE Bekelman, ... Journal of the National Comprehensive Cancer Network 19 (2), 134-143, 2021 | 341 | 2021 |
| Salvage re-irradiation for recurrent head and neck cancer N Lee, K Chan, JE Bekelman, J Zhung, J Mechalakos, A Narayana, ... International Journal of Radiation Oncology* Biology* Physics 68 (3), 731-740, 2007 | 283 | 2007 |
| Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008–2013 JE Bekelman, G Sylwestrzak, J Barron, J Liu, AJ Epstein, G Freedman, ... Jama 312 (23), 2542-2550, 2014 | 221 | 2014 |
| Role of genetic testing for inherited prostate cancer risk: Philadelphia Prostate Cancer Consensus Conference 2017 VN Giri, KE Knudsen, WK Kelly, W Abida, GL Andriole, CH Bangma, ... Journal of Clinical Oncology 36 (4), 414, 2018 | 207 | 2018 |
| Effectiveness of radiation therapy for older women with early breast cancer BD Smith, CP Gross, GL Smith, DH Galusha, JE Bekelman, BG Haffty Journal of the National Cancer Institute 98 (10), 681-690, 2006 | 205 | 2006 |
| Clinically localized prostate cancer: ASCO clinical practice guideline endorsement of an American Urological Association/American Society for Radiation Oncology/Society of … JE Bekelman, RB Rumble, RC Chen, TM Pisansky, A Finelli, A Feifer, ... Journal of clinical oncology: official journal of the American Society of …, 2018 | 201 | 2018 |
| Dose-escalated irradiation and overall survival in men with nonmetastatic prostate cancer A Kalbasi, J Li, AT Berman, S Swisher-McClure, M Smaldone, RG Uzzo, ... JAMA oncology 1 (7), 897-906, 2015 | 177 | 2015 |
| Physician visits prior to treatment for clinically localized prostate cancer TL Jang, JE Bekelman, Y Liu, PB Bach, EM Basch, EB Elkin, MJ Zelefsky, ... Archives of internal medicine 170 (5), 440-450, 2010 | 169 | 2010 |
| Comparative effectiveness of proton vs photon therapy as part of concurrent chemoradiotherapy for locally advanced cancer BC Baumann, N Mitra, JG Harton, Y Xiao, AP Wojcieszynski, PE Gabriel, ... JAMA oncology 6 (2), 237-246, 2020 | 156 | 2020 |
| Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee clinical trials planning meeting, November 6–7, 2011 … DJ Adelstein, JA Ridge, DM Brizel, FC Holsinger, BH Haughey, ... Head & neck 34 (12), 1681-1703, 2012 | 136 | 2012 |
| The rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base JM Martin, EA Handorf, A Kutikov, RG Uzzo, JE Bekelman, EM Horwitz, ... Cancer 120 (14), 2114-2121, 2014 | 125 | 2014 |
| Best practices for reducing unplanned acute care for patients with cancer NR Handley, LM Schuchter, JE Bekelman Journal of oncology practice 14 (5), 306-313, 2018 | 124 | 2018 |
| Correlation of local failure with measures of dose insufficiency in the high-dose single-fraction treatment of bony metastases DM Lovelock, Z Zhang, A Jackson, J Keam, J Bekelman, M Bilsky, E Lis, ... International Journal of Radiation Oncology* Biology* Physics 77 (4), 1282-1287, 2010 | 115 | 2010 |
| Development of a standardized set of patient-centered outcomes for advanced prostate cancer: an international effort for a unified approach AK Morgans, ACM Van Bommel, C Stowell, JL Abrahm, E Basch, ... European urology 68 (5), 891-898, 2015 | 109 | 2015 |
| Association of Medicaid expansion under the Affordable Care Act with insurance status, cancer stage, and timely treatment among patients with breast, colon, and lung cancer SU Takvorian, A Oganisian, R Mamtani, N Mitra, LN Shulman, ... JAMA network open 3 (2), e1921653-e1921653, 2020 | 107 | 2020 |
| Patient‐reported outcomes after 3‐dimensional conformal, intensity‐modulated, or proton beam radiotherapy for localized prostate cancer PJ Gray, JJ Paly, BY Yeap, MG Sanda, HM Sandler, JM Michalski, ... Cancer 119 (9), 1729-1735, 2013 | 104 | 2013 |
| Physician social networks and variation in prostate cancer treatment in three cities CE Pollack, G Weissman, J Bekelman, K Liao, K Armstrong Health services research 47 (1pt2), 380-403, 2012 | 104 | 2012 |
| Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer JE Bekelman, N Mitra, J Efstathiou, K Liao, R Sunderland, DN Yeboa, ... International Journal of Radiation Oncology* Biology* Physics 81 (4), e325-e334, 2011 | 100 | 2011 |
